Detalhe da pesquisa
1.
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer.
Cancer Invest
; 41(9): 789-802, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909664
2.
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.
Eur J Hum Genet
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538877
3.
Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer.
Med Oncol
; 39(12): 233, 2022 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175588
4.
Clinico-Pathologic Profile and Treatment Outcomes of Patients with Diffuse Large B Cell Lymphoma Based on Cell of Origin Classification.
Indian J Hematol Blood Transfus
; 37(2): 226-231, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33867728
5.
Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma.
Ecancermedicalscience
; 15: 1292, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824615
6.
Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India.
Ecancermedicalscience
; 15: 1207, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912232